According to a media report, workers managing records on medical device and tobacco regulations are returning to work after the agency missed court-ordered deadlines for Freedom of Information Act responses. 

Srihari Naidu, MD, spoke to Cardiovascular Business about his plan to take SCAI in some bold new directions.

The proposal would cut funds to the Centers for Disease Control and Prevention and the National Institutes of Health. However, no reduction was suggested for the Food and Drug Administration. 

Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.

The three insurance giants are accused of conspiring with brokers to enroll profitable patients in Medicare Advantage plans, in exchange for "hundreds of millions" in kickbacks.

The vendor's latest earnings report outlines a nearly $35 million decline in mammography sales and projected ramifications from new tariffs. 

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

Local investigative reporters have uncovered details on a scheme in which patients housed at a seedy motel received treatment for drug abuse as part of a massive Medicare fraud operation.